Parallax Volatility Advisers, L.P. Bio N Tech Se Transaction History

Parallax Volatility Advisers, L.P.

$53.5 Billion
Q3 2024

A detailed history of Parallax Volatility Advisers, L.P. transactions in Bio N Tech Se stock. As of the latest transaction made, Parallax Volatility Advisers, L.P. holds 35,000 shares of BNTX stock, worth $3.91 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

35,000

Previous 22,839 53.25%

Holding current value

$3.91 Million

Previous $1.84 Million 126.49%

% of portfolio

0.01%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$78.36 - $124.66 $1.13 Million - $1.79 Million	-14,382 Reduced 62.97%	8,457 $1 Million
Q2 2024 Aug 14, 2024	SELL	$80.36 - $102.87 $1.28 Million - $1.64 Million	-15,990 Reduced 41.18%	22,839 $1.84 Million
Q1 2024 May 15, 2024	BUY	$88.96 - $112.35 $1.13 Million - $1.42 Million	12,683 Added 48.51%	38,829 $3.58 Million
Q4 2023 Feb 14, 2024	SELL	$90.91 - $112.75 $241,093 - $299,013	-2,652 Reduced 9.21%	26,146 $2.76 Million
Q3 2023 Nov 14, 2023	SELL	$98.5 - $125.08 $1.58 Million - $2.01 Million	-16,083 Reduced 35.83%	28,798 $3.13 Million
Q2 2023 Aug 14, 2023	BUY	$102.58 - $129.66 $3.58 Million - $4.53 Million	34,940 Added 351.47%	44,881 $4.84 Million
Q1 2023 May 15, 2023	SELL	$122.57 - $153.67 $4.43 Million - $5.56 Million	-36,175 Reduced 78.44%	9,941 $1.24 Million
Q4 2022 Feb 14, 2023	SELL	$118.43 - $186.05 $115,587 - $181,584	-976 Reduced 2.07%	46,116 $6.93 Million
Q3 2022 Nov 14, 2022	BUY	$127.65 - $183.11 $3.69 Million - $5.3 Million	28,923 Added 159.19%	47,092 $6.35 Million
Q2 2022 Aug 15, 2022	SELL	$123.25 - $186.24 $6.39 Million - $9.66 Million	-51,849 Reduced 74.05%	18,169 $2.71 Million
Q1 2022 May 16, 2022	BUY	$126.25 - $231.85 $4.79 Million - $8.8 Million	37,956 Added 118.38%	70,018 $11.9 Million
Q4 2021 Feb 14, 2022	SELL	$216.64 - $362.52 $1.42 Million - $2.38 Million	-6,566 Reduced 17.0%	32,062 $8.27 Million
Q3 2021 Nov 15, 2021	BUY	$205.93 - $447.23 $4.69 Million - $10.2 Million	22,760 Added 143.43%	38,628 $10.5 Million
Q2 2021 Aug 16, 2021	SELL	$113.32 - $241.49 $233,212 - $496,986	-2,058 Reduced 11.48%	15,868 $3.55 Million
Q1 2021 May 14, 2021	BUY	$85.73 - $119.5 $1.27 Million - $1.77 Million	14,775 Added 468.9%	17,926 $1.96 Million
Q4 2020 Feb 16, 2021	BUY	$72.71 - $129.54 $229,109 - $408,180	3,151 New	3,151 $257,000

Others Institutions Holding BNTX

# of Institutions

357

Shares Held

38.3M

Call Options Held

2.45M

Put Options Held

2.29M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $27.1B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.

Account

Parallax Volatility Advisers, L.P. Bio N Tech Se Transaction History